Download PDF
Osteologie 2022; 31(03): 162-169
DOI: 10.1055/a-1913-7112
Review

Anorexia nervosa und Knochen

Anorexia nervosa and Bone
Thomas Brabant
1   Kardiologisch-Angiologische Praxis Herzzentrum Bremen, Bremen, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Die Anorexia nervosa ist eine psychische Erkrankung noch unbekannter Ätiologie, die durch eine reduzierte Nahrungsaufnahme, deutliche Gewichtsabnahme sowie Angst vor Gewichtszunahme charakterisiert ist. Sie verursacht eine Vielzahl endokrinologischer Veränderungen, wobei das Ausmaß dieser Veränderungen mit dem Grad der Unterernährung zusammenhängt. In Anpassung an diesen Hungerzustand kommt es zu einer deutlichen Veränderung einer Vielzahl von Hormonen und Signalpeptiden, wobei endokrinologische Achsen mit Beteiligung von Hypothalamus, Hypophyse, Gonaden bzw Nebenniere ebenso betroffen sind wie IGF-1 und die Adipokine Leptin, Ghrelin und PPY. Eine wesentliche Komorbidität ist die Reduktion der Knochendichte bis zur Entwicklung einer Osteoporose und die mit ihr verbundene Entwicklung eines erhöhten Frakturrisikos. Dabei sind sowohl der trabeculäre wie auch der corticale Knochen betroffen. Die Wiederherstellung des Gewichts und die Wiederaufnahme der Menstruation haben den stärksten Einfluß auf die Knochenmineraldichte. Zu den weiteren Behandlungsmöglichkeiten gehören neben der grundsätzlichen Psychotherapie die transdermale Therapie mit Östrogen bzw. die subcutane Gabe von Teriparatid.

Abstract

Anorexia nervosa is a psychological disorder of still unknown etiology characterized by reduced food intake, marked weight loss and fear of gaining weight. It causes a variety of endocrinological changes, the extent of which is related to the degree of malnutrition. In adaptation to this state of hunger, there is a marked change in a variety of hormones and signal peptides, with endocrinological axes involving the hypothalamus, pituitary, gonads and adrenal glands, as well as IGF-1 and the adipokines leptin, ghrelin and PPY. A major comorbidity is the reduction of bone density to the development of osteoporosis and the associated development of increased fracture risk. Both trabecular and cortical bone are affected. Restoration of weight and resumption of menstruation have the strongest influence on bone mineral density. Other treatment options include, in addition to basic psychotherapy, transdermal therapy with estrogen or subcutaneous administration of teriparatide.

Schlüsselwörter

Anorexia nervosa - Knochen - Osteoporose - Frakturrisiko

Key words

anorexia nervosa - bone - osteoporosis - fracture risk


Publication History

Received: 20 May 2022

Accepted: 29 July 2022

Article published online:
08 September 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Edition F.. Diagnostic and statistical manual of mental disorders. Am Psychiatric Assoc 2013; 21: 591-643
    Search in Google Scholar
  • 2 Hudson JI, Hiripi E, Pope HG. et al. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61: 348-358
    CrossrefPubMedSearch in Google Scholar
  • 3 Keski-Rahkonen A, Hoek HW, Susser ES. et al. Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry 2007; 164: 1259-1265
    CrossrefPubMedSearch in Google Scholar
  • 4 Roux H, Chapelon E, Godart N.. Epidemiology of anorexia nervosa: a review. Encephale 2013; 39: 85-93
    CrossrefPubMedSearch in Google Scholar
  • 5 Franko DL, Keshaviah A, Eddy KT. et al. A longitudinal investigation of mortality in anorexia nervosa and bulimia nervosa. Am J Psychiatry 2013; 170: 917-925
    CrossrefPubMedSearch in Google Scholar
  • 6 Fazeli PK, Klibanski A.. Effects of Anorexia Nervosa on Bone Metabolism. Endocr Rev 2018; 39: 895-910
    CrossrefPubMedSearch in Google Scholar
  • 7 Nagl M, Jacobi C, Paul M. et al. Prevalence, incidence, and natural course of anorexia and bulimia nervosa among adolescents and young adults. Eur Child Adolesc Psychiatry 2016; 25: 903-918
    CrossrefPubMedSearch in Google Scholar
  • 8 Berkman ND, Lohr KN, Bulik CM.. Outcomes of eating disorders: a systematic review of the literature. Int J Eat Disord 2007; 40: 293-309
    CrossrefPubMedSearch in Google Scholar
  • 9 Godart NT, Perdereau F, Rein Z. et al. Comorbidity studies of eating disorders and mood disorders. Critical review of the literature. J Affect Disord 2007; 97: 37-49
    CrossrefPubMedSearch in Google Scholar
  • 10 Pepe J, Body JJ, Hadji P. et al. Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF. J Clin Endocrinol Metab 2020; 105
    CrossrefPubMedSearch in Google Scholar
  • 11 Schorr M, Thomas JJ, Eddy KT. et al. Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord 2017; 50: 343-351
    CrossrefPubMedSearch in Google Scholar
  • 12 Solmi M, Veronese N, Correll CU. et al. Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 2016; 133: 341-351
    CrossrefPubMedSearch in Google Scholar
  • 13 Miller KK, Grinspoon SK, Ciampa J. et al. Medical findings in outpatients with anorexia nervosa. Arch Intern Med 2005; 165: 561-566
    CrossrefPubMedSearch in Google Scholar
  • 14 Bolton JG, Patel S, Lacey JH. et al. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 2005; 16: 1955-1962
    CrossrefPubMedSearch in Google Scholar
  • 15 Ilich JZ, Skugor M, Hangartner T. et al. Relation of nutrition, body composition and physical activity to skeletal development: a cross-sectional study in preadolescent females. J Am Coll Nutr 1998; 17: 136-147
    CrossrefPubMedSearch in Google Scholar
  • 16 Castro J, Toro J, Lazaro L. et al. Bone mineral density in male adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2002; 41: 613-618
    CrossrefPubMedSearch in Google Scholar
  • 17 Misra M, Klibanski A.. Bone health in anorexia nervosa. Curr Opin Endocrinol Diabetes Obes 2011; 18: 376-382
    CrossrefPubMedSearch in Google Scholar
  • 18 Misra M, Klibanski A.. Anorexia nervosa and bone. J Endocrinol 2014; 221: R163-R176
    CrossrefPubMedSearch in Google Scholar
  • 19 Misra M, Golden NH, Katzman DK.. State of the art systematic review of bone disease in anorexia nervosa. Int J Eat Disord 2016; 49: 276-292
    CrossrefPubMedSearch in Google Scholar
  • 20 Milos G, Spindler A, Rüegsegger P. et al. Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 2005; 16: 783-790
    CrossrefPubMedSearch in Google Scholar
  • 21 Misra M, Aggarwal A, Miller KK. et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004; 114: 1574-1583
    CrossrefPubMedSearch in Google Scholar
  • 22 Misra M, Klibanski A.. Bone metabolism in adolescents with anorexia nervosa. J Endocrinol Invest 2011; 34: 324-332
    CrossrefPubMedSearch in Google Scholar
  • 23 Gordon CM.. Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med 2010; 363: 365-371
    CrossrefPubMedSearch in Google Scholar
  • 24 Misra M, Klibanski A.. The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism. Neuroendocrinology 2011; 93: 65-73
    CrossrefPubMedSearch in Google Scholar
  • 25 Schorr M, Miller KK.. The endocrine manifestations of anorexia nervosa: mechanisms and management. Nat Rev Endocrinol 2017; 13: 174-186
    CrossrefPubMedSearch in Google Scholar
  • 26 Misra M, Miller KK, Bjornson J. et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003; 88: 5615-5623
    CrossrefPubMedSearch in Google Scholar
  • 27 Monteleone AM, Monteleone P, Serino I. et al. Underweight subjects with anorexia nervosa have an enhanced salivary cortisol response not seen in weight restored subjects with anorexia nervosa. Psychoneuroendocrinology 2016; 70: 118-121
    CrossrefPubMedSearch in Google Scholar
  • 28 Milos G, Hebebrand J.. Endocrine Consequences of Anorexia Nervosa. Praxis (Bern 1994) 2019; 108: 899-904
    CrossrefPubMedSearch in Google Scholar
  • 29 Oztas B, Sahin D, Kir H. et al. Effects of leptin, ghrelin and neuropeptide y on spike-wave discharge activity and certain biochemical parameters in WAG/Rij rats with genetic absence epilepsy. J Neuroimmunol 2021; 351: 577454
    CrossrefPubMedSearch in Google Scholar
  • 30 Reseland JE, Syversen U, Bakke I. et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001; 16: 1426-1433
    CrossrefPubMedSearch in Google Scholar
  • 31 Lee NJ, Wong IP, Baldock PA. et al. Leptin as an endocrine signal in bone. Curr Osteoporos Rep 2008; 6: 62-66
    CrossrefPubMedSearch in Google Scholar
  • 32 Misra M, Klibanski A.. Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol 2014; 2: 581-592
    CrossrefPubMedSearch in Google Scholar
  • 33 Kim SW, Her SJ, Park SJ. et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 2005; 37: 359-369
    CrossrefPubMedSearch in Google Scholar
  • 34 Misra M, Miller KK, Stewart V. et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005; 90: 5082-5087
    CrossrefPubMedSearch in Google Scholar
  • 35 Gorwood P, Blanchet-Collet C, Chartrel N. et al. New Insights in Anorexia Nervosa. Front Neurosci 2016; 10: 256
    CrossrefPubMedSearch in Google Scholar
  • 36 Hotta M, Ohwada R, Akamizu T. et al. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr J 2009; 56: 1119-1128
    CrossrefPubMedSearch in Google Scholar
  • 37 Misra M, Miller KK, Tsai P. et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006; 91: 1027-1033
    CrossrefPubMedSearch in Google Scholar
  • 38 Wong IP, Driessler F, Khor EC. et al. Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One 2012; 7: e40038
    CrossrefPubMedSearch in Google Scholar
  • 39 Hung C, Muñoz M, Shibli-Rahhal A.. Anorexia Nervosa and Osteoporosis. Calcif Tissue Int 2022; 110: 562-575
    CrossrefPubMedSearch in Google Scholar
  • 40 Fazeli PK.. Low bone mineral density in anorexia nervosa: Treatments and challenges. Clin Rev Bone Miner Metab 2019; 17: 65-76
    CrossrefPubMedSearch in Google Scholar
  • 41 Lubkowska A, Dobek A, Mieszkowski J. et al. Adiponectin as a biomarker of osteoporosis in postmenopausal women: controversies. Dis Markers 2014; 2014: 975178
    CrossrefPubMedSearch in Google Scholar
  • 42 Steinman J, Shibli-Rahhal A.. Anorexia Nervosa and Osteoporosis: Pathophysiology and Treatment. J Bone Metab 2019; 26: 133-143
    CrossrefPubMedSearch in Google Scholar
  • 43 Jäger B, Herpertz S.. S3-Leitlinie Diagnostik und Therapie der Essstörungen. PiD-Psychotherapie im. Dialog 2013; 14: 16-21
    Search in Google Scholar
  • 44 Lucas AR, Melton LJ, Crowson CS. et al. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999; 74: 972-977
    CrossrefPubMedSearch in Google Scholar
  • 45 Miller KK, Lee EE, Lawson EA. et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006; 91: 2931-2937
    CrossrefPubMedSearch in Google Scholar
  • 46 Legroux I, Cortet B.. Factors influencing bone loss in anorexia nervosa: assessment and therapeutic options. RMD Open 2019; 5: e001009
    CrossrefPubMedSearch in Google Scholar
  • 47 Klibanski A, Biller BM, Schoenfeld DA. et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80: 898-904
    CrossrefPubMedSearch in Google Scholar
  • 48 Golden NH, Lanzkowsky L, Schebendach J. et al. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 2002; 15: 135-143
    CrossrefPubMedSearch in Google Scholar
  • 49 Misra M, Katzman D, Miller KK. et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011; 26: 2430-2438
    CrossrefPubMedSearch in Google Scholar
  • 50 Miller KK, Meenaghan E, Lawson EA. et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2011; 96: 2081-2088
    CrossrefPubMedSearch in Google Scholar
  • 51 Miller KK, Grieco KA, Mulder J. et al. Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 2004; 89: 3903-3906
    CrossrefPubMedSearch in Google Scholar
  • 52 Golden NH, Iglesias EA, Jacobson MS. et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90: 3179-3185
    CrossrefPubMedSearch in Google Scholar
  • 53 Fazeli PK, Wang IS, Miller KK. et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab 2014; 99: 1322-1329
    CrossrefPubMedSearch in Google Scholar
  • 54 Milos G, Moergeli H, Sob C. et al. Positive Effect of Teriparatide on Areal Bone Mineral Density in Young Women with Anorexia Nervosa: A Pilot Study. Calcif Tissue Int 2021; 108: 595-604
    CrossrefPubMedSearch in Google Scholar
  • 55 Miller K.. Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study. In:. https://ClinicalTrials.gov/show/NCT03292146
  • 56 Steinhausen HC.. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 2002; 159: 1284-1293
    CrossrefPubMedSearch in Google Scholar
  • 57 Strokosch GR, Friedmann AJ, WU SC, Kamin M.. Effects of an oral contraceptive(norgestimate/ethinyl estradiol ) obn bone mineral density in adolescent females with anorexia nervosa: a double-blind placebo-controlled study. J Adolesc Health 2006; 39: 819-827
    CrossrefPubMedSearch in Google Scholar